Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKBA | ENTA | NBTX | ||
| Company | Akebia Therapeutics | Enanta Pharmaceutica | Nanobiotix S.A. ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.3100 | 13.22 | 5.83 | ||
| High | 1.3200 | 14.10 | 5.84 | ||
| Low | 1.2300 | 12.87 | 5.71 | ||
| Last | 1.2600 | 13.74 | 5.84 | ||
| Change | -0.0600 | +0.49 | +0.03 | ||
| % Change | -4.55% | +3.70% | +0.52% | ||
| Volume | 4,647,800 | 148,400 | 1,100 | ||
| 20-Day Average Volume | 3,616,970 | 166,180 | 90,140 | ||
| Previous Close | 1.3200 | 13.25 | 5.81 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.4195 | 14.79 | 5.89 | ||
| 20-Day Raw Stochastic | 7.69% | 28.47% | 48.30% | ||
| 20-Day Relative Strength | 38.58% | 46.39% | 46.02% | ||
| Weighted Alpha | -8.60 | -48.35 | -27.59 | ||
| Today's Opinion | 24% Sell | 56% Buy | 100% Sell | ||
| Previous Opinion | 8% Sell | 56% Buy | 100% Sell | ||
| Last Month's Opinion | 88% Buy | 88% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.03% since 04/23/24 | +4.49% since 04/23/24 | +2.28% since 04/23/24 | ||
| Low | 1.2300 on 04/30/24 | 12.20 on 04/26/24 | 5.70 on 04/29/24 | ||
| High | 1.4000 on 04/24/24 | 14.10 on 04/30/24 | 6.30 on 04/29/24 | ||
| 1-Month | |||||
| %Chg | -31.15% since 03/28/24 | -21.31% since 03/28/24 | -10.15% since 03/28/24 | ||
| Low | 1.2300 on 04/30/24 | 12.20 on 04/26/24 | 5.13 on 04/17/24 | ||
| High | 1.9300 on 04/01/24 | 17.80 on 04/01/24 | 6.60 on 04/05/24 | ||
| 3-Month | |||||
| %Chg | -23.17% since 01/30/24 | +12.62% since 01/30/24 | -25.51% since 01/30/24 | ||
| Low | 1.2300 on 04/30/24 | 11.01 on 02/08/24 | 5.13 on 04/17/24 | ||
| High | 2.4800 on 03/28/24 | 17.80 on 04/01/24 | 8.08 on 01/31/24 | ||
| 6-Month | |||||
| %Chg | +48.97% since 10/30/23 | +55.78% since 10/30/23 | -7.89% since 10/30/23 | ||
| Low | 0.8360 on 10/31/23 | 8.08 on 11/10/23 | 5.00 on 11/02/23 | ||
| High | 2.4800 on 03/28/24 | 17.80 on 04/01/24 | 8.96 on 01/18/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 276,371 | 280,317 | 273,843 | ||
| Shares Outstanding, K | 209,372 | 21,156 | 47,133 | ||
| Annual Sales | 194,620,000 | 79,200,000 | 5,030,000 | ||
| Annual Net Income | -51,930,000 | -133,820,000 | -60,100,000 | ||
| Last Quarter Sales | 56,070,000 | 18,000,000 | N/A | ||
| Last Quarter Net Income | -50,000 | -33,410,000 | N/A | ||
| 60-Month Beta | 0.79 | 0.47 | 0.21 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 03/14/24 | -1.58 on 02/07/24 | N/A | ||
| Latest Earnings Date | 05/13/24 | 05/13/24 | 04/22/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||